CD4 and graft versus host disease: Consistent with the lowest pathogenicity of Fli1Het T cells for GVHD induction, we observed that Fli1Het CD4+ T cells had the lowest Th1/Th17 pathway enrichment and TCR pathway downstream gene expression.